Ads
related to: canada approved weight loss drugs prescription fda approvedbest-weightloss-meds.com has been visited by 10K+ users in the past month
joinmidi.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
The approval is the second indication for Zepbound, which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023.
Last month, the FDA approved it for use in chronic weight management, placing an official stamp of approval on a medicine widely prescribed off-label for weight loss.
Originally available only by prescription, it was approved by the FDA for over-the-counter sale in February 2007. [32] In May 2010, the U.S. Food and Drug Administration (FDA) approved a revised label for Xenical to include new safety information about rare cases of severe liver injury that have been reported with the use of this medication. [33]
Tirzepatide was approved for treatment of diabetes in the United States in May 2022, [9] [13] in the European Union in September 2022, [11] in Canada in November 2022, [19] and in Australia in December 2022. [2] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.
The FDA’s approval of tirzepatide, following the approval of semaglutide in 2021, gives doctors and patients two of the most potent drugs yet to treat weight loss.
Ads
related to: canada approved weight loss drugs prescription fda approvedjoinmidi.com has been visited by 10K+ users in the past month